Literature DB >> 24496037

MicroRNAs and SerpinB3 in hepatocellular carcinoma.

Cristian Turato1, Davide Simonato1, Santina Quarta1, Angelo Gatta1, Patrizia Pontisso2.   

Abstract

miRNAs are small non-coding RNAs which target complementary mRNA sequences, usually resulting in gene silencing. They can exhibit oncogenic or tumor suppressor properties, modulating cell homeostasis. Several data have documented that miRNAs are typically deregulated in different types of cancers, including hepatocellular carcinoma (HCC). Some of the miRNAs such as miR-122, miR-221, miR-1 and miR-21 have been found to repress post-transcriptionally the expression of genes involved in cell cycle regulation, cell proliferation, apoptosis, cell migration and invasion. In HCC serum levels of miR-122, miR-221 and miR-16 have been described deregulated, suggesting that they may be used as molecular targets for early detection, prognosis and treatment. The ov-serpin SerpinB3 was found previously increased in liver tumor cancers and associated with apoptosis resistance, increased cell proliferation and invasiveness. Recent data indicate that this serpin may enhance its oncogenic potential through inhibition of several tumor suppressive miRNAs, typically described in HCC.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Primary liver cancer; SerpinB3; Small non coding RNA

Mesh:

Substances:

Year:  2014        PMID: 24496037     DOI: 10.1016/j.lfs.2014.01.073

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  8 in total

1.  Dehydroepiandrosterone Activation of G-protein-coupled Estrogen Receptor Rapidly Stimulates MicroRNA-21 Transcription in Human Hepatocellular Carcinoma Cells.

Authors:  Yun Teng; Brandie N Radde; Lacey M Litchfield; Margarita M Ivanova; Russell A Prough; Barbara J Clark; Mark A Doll; David W Hein; Carolyn M Klinge
Journal:  J Biol Chem       Date:  2015-05-11       Impact factor: 5.157

2.  SERPINB3 (serpin peptidase inhibitor, clade B (ovalbumin), member 3).

Authors:  Cristian Turato; Patrizia Pontisso
Journal:  Atlas Genet Cytogenet Oncol Haematol       Date:  2015

Review 3.  Tumor suppressor maspin as a modulator of host immune response to cancer.

Authors:  Sijana H Dzinic; Maria M Bernardo; Daniel S M Oliveira; Marian Wahba; Wael Sakr; Shijie Sheng
Journal:  Bosn J Basic Med Sci       Date:  2015-10-25       Impact factor: 3.363

Review 4.  MicroRNA-1 in Cardiac Diseases and Cancers.

Authors:  Jianzhe Li; Xiaomin Dong; Zhongping Wang; Jianhua Wu
Journal:  Korean J Physiol Pharmacol       Date:  2014-10-17       Impact factor: 2.016

5.  Downregulation of microRNA-122 promotes proliferation, migration, and invasion of human hepatocellular carcinoma cells by activating epithelial-mesenchymal transition.

Authors:  Nanyao Wang; Qiong Wang; Dong Shen; Xia Sun; Xiangming Cao; Dan Wu
Journal:  Onco Targets Ther       Date:  2016-04-06       Impact factor: 4.147

6.  Anti-microRNA-21/221 and microRNA-199a transfected by ultrasound microbubbles induces the apoptosis of human hepatoma HepG2 cells.

Authors:  Xinmin Guo; Shunhua Guo; Liwen Pan; Li Ruan; Yingshi Gu; Jichuang Lai
Journal:  Oncol Lett       Date:  2017-03-24       Impact factor: 2.967

7.  MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma.

Authors:  Cristian Turato; Francesca Fornari; Daniela Pollutri; Matteo Fassan; Santina Quarta; Gianmarco Villano; Mariagrazia Ruvoletto; Luigi Bolondi; Laura Gramantieri; Patrizia Pontisso
Journal:  J Clin Med       Date:  2019-02-01       Impact factor: 4.241

8.  SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity.

Authors:  Cristian Turato; Stefania Cannito; Davide Simonato; Gianmarco Villano; Elisabetta Morello; Liliana Terrin; Santina Quarta; Alessandra Biasiolo; Mariagrazia Ruvoletto; Andrea Martini; Silvano Fasolato; Giacomo Zanus; Umberto Cillo; Angelo Gatta; Maurizio Parola; Patrizia Pontisso
Journal:  Sci Rep       Date:  2015-12-04       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.